Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Verana Health Secures $150M Series E

2022-01-14
SAN FRANCISCO, CA, Verana Health, a digital health company, announced a $150 million Series E funding round led by Johnson & Johnson Innovation and Novo Growth.
Verana Health, a digital health company, announced a $150 million Series E funding round led by Johnson & Johnson Innovation - JJDC, Inc. (JJDC) and Novo Growth, the growth-stage investment arm of Novo Holdings.

Existing Verana Health investors GV (formerly Google Ventures), Casdin Capital, and Brook Byers also joined the round, as well as notable new investors, including the Merck Global Health Innovation Fund, THVC, and Breyer Capital.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors


Featured Reading